Skip to main content

Advertisement

SpringerLink
Log in

The use of nutraceuticals in male sexual and reproductive disturbances: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)

  • Consensus Statement
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

ART:

Assisted reproductive technology

BPH:

Benign prostatic hyperplasia

DHEAS:

Dehydroepiandrosteronesulfate

EAU:

European Association of Urology

EBM:

Evidence-based medicine

ED:

Erectile dysfunction

GSH:

Glutathione

IPSS:

International prostatic symptoms score

LUTS:

Lower urinary tract symptoms

MDA:

Malonyldialdehyde

MYO:

Myoinositol

N:

Nutraceuticals

NAC:

N-acetyl-cysteine

NO:

Nitric oxide

OAT:

Oligo-astheno-teratozoospermia

OS:

Oxidative stress

PDE5i:

Type 5 phosphodiesterase inhibitors

RCT:

Randomized controlled study

ROS:

Reactive oxygen species

SDF:

Sperm DNA fragmentation

Vit. B:

Vitamin B

Vit. C:

Vitamin C

Vit. E:

Vitamin E

References

  1. Brower V (2005) A nutraceutical a day may keep the doctor away. EMBO Rep 6:708–711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Calogero AE, Condorelli RA, Russo GI, La Vignera S (2017) Conservative nonhormonal options for the treatment of male infertility: antibiotics, anti-inflammatory drugs, and antioxidants. Biomed Res Int 2017:4650182

    Article  PubMed  PubMed Central  Google Scholar 

  3. Malde S, Nambiar AK, Umbach R, Lam TB, Bach T, Bachmann A, Drake MJ, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KA, Gravas S (2017) Systematic review of the performance of noninvasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms. European Association of Urology Non-Neurogenic Male LUTS guidelines panel. Eur Urol 71:391–402

    Article  PubMed  Google Scholar 

  4. Krausz C (2011) Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab 25:271–285

    Article  PubMed  Google Scholar 

  5. Gabrielsen JS, Tanrikut C (2016) Chronic exposures and male fertility: the impacts of environment, diet, and drug use on spermatogenesis. Andrology 4:648–661

    Article  CAS  PubMed  Google Scholar 

  6. Ferlin A, Foresta C (2014) New genetic markers for male infertility. Curr Opin Obstet Gynecol 26:193–198

    Article  PubMed  Google Scholar 

  7. Cui T, Kovell RC, Brooks DC, Terlecki RP (2015) A urologist’s guide to ingredients found in top-selling nutraceuticals for men’s sexual health. J Sex Med 12:2105–2117

    Article  CAS  PubMed  Google Scholar 

  8. European Monitoring Centre for Drugs and Drug Addictions (2012) Annual report on the state of the drugs problem in Europe. http://www.emcdda.europa.eu/publications/annual-report/2012. Accessed 03 Mar 2017

  9. Swiglo BA, Murad MH, Schünemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM (2008) A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93:666–673

    Article  CAS  PubMed  Google Scholar 

  10. Balercia G, Gandini L, Lenzi A, Lombardo F (2017) Antioxydants in andrology. Springer, Cham, Switzerland

    Book  Google Scholar 

  11. Tremellen K (2008) Oxidative stress and male infertility—a clinical perspective. Hum Reprod Update 14:243–258

    Article  CAS  PubMed  Google Scholar 

  12. Bykova M, Athayde K, Sharma R, Jha R, Sabanegh E, Agarwal A (2007) Defining the reference value of seminal reactive oxygen species in a population of infertile men and normal healthy volunteers. Fertil Steril 88:305

    Article  Google Scholar 

  13. Agarwal A, Allamaneni SS, Nallella KP, George AT, Mascha E (2005) Correlation of reactive oxygen species levels with the fertilization rate after in vitro fertilization: a qualified meta-analysis. Fertil Steril 84:228–231

    Article  CAS  PubMed  Google Scholar 

  14. Tamburrino L, Marchiani S, Montoya M, Elia Marino F, Natali I, Cambi M, Forti G, Baldi E, Muratori M (2012) Mechanisms and clinical correlates of sperm DNA damage. Asian J Androl 14:24–31

    Article  CAS  PubMed  Google Scholar 

  15. Robinson L, Gallos ID, Conner SJ, Rajkhowa M, Miller D, Lewis S, Kirkman-Brown J, Coomarasamy A (2012) The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum Reprod 27:2908–2917

    Article  CAS  PubMed  Google Scholar 

  16. Osman A, Alsomait H, Seshadri S, El-Toukhy T, Khalaf Y (2015) The effect of sperm DNA fragmentation on live birth rate after IVF or ICSI: a systematic review and meta-analysis. Reprod Biomed Online 30:120–127

    Article  CAS  PubMed  Google Scholar 

  17. Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ (2014) Antioxidants for male subfertility. Cochrane Database Syst Rev 12:CD00741

  18. Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ (2011) Antioxidants for male subfertility. Cochrane Database Syst Rev 1:CD007411

  19. Filippi S, Luconi M, Granchi S, Natali A, Tozzi P, Forti G, Ledda F, Maggi M (2002) Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation. Int J Impot Res 14:295–307

    Article  CAS  PubMed  Google Scholar 

  20. Ernst E, Pittler MH (1998) Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 159:433–436

    Article  CAS  PubMed  Google Scholar 

  21. Qureshi A, Naughton DP, Petroczi A (2014) A systematic review on the herbal extract Tribulus terrestris and the roots of its putative aphrodisiac and performance enhancing effect. J Diet Suppl 11:64–79

    Article  PubMed  Google Scholar 

  22. Kamenov Z, Fileva S, Kalinov K, Jannini EA (2017) Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction? A prospective, randomized, double-blind, placebo-controlled clinical trial. Maturitas 99:20–26

    Article  PubMed  Google Scholar 

  23. Corona G, Rastrelli G, Giagulli VA, Sila A, Sforza A, Forti G, Mannucci E, Maggi M (2013) Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. J Clin Endocrinol Metab 98:3615–3626

    Article  CAS  PubMed  Google Scholar 

  24. Cui T, Kovell RC, Brooks DC, Terlecki RP (2015) A urologist’s guide to ingredients found in top-selling nutraceuticals for men’s sexual health. J Sex Med 12:2105–2117

    Article  CAS  PubMed  Google Scholar 

  25. Mollace V, Malara N, Gratteri S, Palma E, Zappia L, Costa N, Rosano G, Paone S (2016) Bergamot polyphenolic fraction counteracts erectile dysfunction occurring in patients suffering from type 2 diabetes. Pharmanutrition 4S:S41–S46

    Article  Google Scholar 

  26. Rastrelli G, Corona G, Tarocchi M, Mannucci E, Maggi M (2016) How to define hypogonadysm? Results from a population of men consulting for sexual dysfunction. J Endocrinol Invest 39:473–484

    Article  CAS  PubMed  Google Scholar 

  27. Isidori AM, Balercia G, Calogero AE, Corona Ferlin G, Francavilla A, Santi D, Maggi M (2015) Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology. J Endocrinol Invest 38:103–112

    Article  CAS  PubMed  Google Scholar 

  28. Jang DJ, Lee MS, Shin BC, Lee YC, Ernst E (2008) Red ginseng for treating erectile dysfunction: a systematic review. Br J Clin Pharmacol 66:444–450

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lombardo F, Sgrò P, Gandini L, Dondero F, Jannini EA, Lenzi A (2004) Might erectile dysfunction be due to the thermolabile variant of methylenetetrahydrofolate reductase? J Endocrinol Invest 27(9):883–885

    Article  CAS  PubMed  Google Scholar 

  30. Lombardo F, Tsamatropoulos P, Piroli E, Culasso F, Jannini EA, Dondero F, Lenzi A, Gandini L (2010) Treatment of erectile dysfunction due to C677T mutation of the MTHFR gene with vitamin B6 and folic acid in patients non responders to PDE5i. J Sex Med 7(1 Pt 1):216–223

    Article  CAS  PubMed  Google Scholar 

  31. Rastelli G, Giovannini L, Calogero AE, Gianfrilli D, Serra E, Pizzocaro A, Giagulli VA, Motta G, Vancieri G, Sperandio A, Andò S, Selice R, Luca G, Cocchiara F, Canale D, Maggi M (2016) Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry. J Endocrinol Invest 39:695–708

    Article  Google Scholar 

  32. Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G (2002) Pygeumafricanum for benign prostatic hyperplasia. Cochrane Database Syst Rev 1:CD001044

    Google Scholar 

  33. Wilt TJ, Macdonald R, Ishani A, Rutks I, Stark G (2011) WITHDRAWN: cernilton for benign prostatic hyperplasia. Cochrane Database Syst Rev 5:CD001042

    Google Scholar 

  34. Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ (2012) Serenoarepens for benign prostatic hyperplasia. Cochrane Database Syst Rev 12:CD001423

    PubMed  Google Scholar 

  35. Morgia G, Russo GI, Voce S, Palmieri F, Gentile M, Giannantoni A, Blefari F, Carini M, Minervini A, Ginepri A, Salvia G, Vespasiani G, Santelli G, Cimino S, Allegro R, Collura Z, Fragalà E, Arnone S, Pareo RM (2014) Serenoarepens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial). Prostate 74:1471–1480

    Article  CAS  PubMed  Google Scholar 

  36. Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M, Thakkinstian A (2011) Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 305:78–86

    Article  CAS  PubMed  Google Scholar 

  37. Festuccia C, Mancini A, Gravina GL, Scarsella L, Llorens S, Alonso GL, Tatone C, Di Cesare E, Jannini EA, Lenzi A, D’Alessandro AM, Carmona M (2014) Antitumoreffects of saffron-derived carotenoids in prostate cancercellmodels. Biomed Res Int 2014:135048

    Article  PubMed  PubMed Central  Google Scholar 

  38. Mishra M, Acharya UR (2004) Protective action of vitamins on the spermatogenesis in lead-treated Swiss mice. J Trace Elem Med Biol 18:173–178

    Article  CAS  PubMed  Google Scholar 

  39. Song GJ, Norkus EP, Lewis V (2006) Relationship between seminal ascorbic acid and sperm DNA integrity in infertile men. Int J Androl 29:569–575

    Article  CAS  PubMed  Google Scholar 

  40. Moncada LM, Vicari E, Cimino C, Calogero AE, Mongioì A, D’Agata R (1992) Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil 23:221–224

    CAS  PubMed  Google Scholar 

  41. Costa M, Canale D, Filicori M, D’lddio S, Lenzi A (1994) l-Carnitine in idiopathic asthenozoospermia: a multicenterstudy. Andrologia 26:155–159

    Article  CAS  PubMed  Google Scholar 

  42. Vitali G, Parente R, Melotti C (1995) Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res 21:157–159

    CAS  PubMed  Google Scholar 

  43. Banihani S, Agarwal A, Sharma R, Bayachou M (2014) Cryoprotective effect of l-carnitine on motility, vitality and DNA oxidation of human spermatozoa. Andrologia 46:637–641

    Article  CAS  PubMed  Google Scholar 

  44. Vicari E, La Vignera S, Calogero AE (2002) Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds. Fertil Steril 78:1203–1208

    Article  PubMed  Google Scholar 

  45. Gupta NP, Kumar R (2002) Lycopene therapy in idiopathic male infertility—a preliminary report. Int Urol Nephrol 34:369–372

    Article  CAS  PubMed  Google Scholar 

  46. Mongioì LM, Calogero AE, Vicari E, Condorelli RA, Russo GI, Privitera S, Morgia G, La Vignera S (2016) The role of carnitine in male infertility. Andrology 4:800–807

    Article  PubMed  Google Scholar 

  47. Balercia G, Mancini A, Paggi F, Tiano L, Pontecorvi A, Boscaro M, Lenzi A, Littarru GP (2009) Coenzyme Q10 and male infertility. J Endocrinol Invest 32:626–632

    Article  CAS  PubMed  Google Scholar 

  48. Balercia G, Buldreghini E, Vignini A, Tiano L, Paggi F, Amoroso S, Ricciardo-Lamonica G, Boscaro M, Lenzi A, Littarru G (2009) Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril 91:1785–1792

    Article  CAS  PubMed  Google Scholar 

  49. Safarinejad MR, Safarinejad S (2009) Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol 181:741–751

    Article  CAS  PubMed  Google Scholar 

  50. Nadjarzadeh A, Sadeghi MR, Amirjannati N, Vafa MR, Motevalian SA, Gohari MR, Akhondi MA, Yavari P, Shidfar F (2011) Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia: a randomized double-blind, placebo controlled trial. J Endocrinol Invest 34:224–228

    Google Scholar 

  51. Condorelli RA, La Vignera S, Di Bari F, Unfer V, Calogero AE (2011) Effects of myoinositol on sperm mitochondrial function in-vitro. Eur Rev Med Pharmacol Sci 15:129–134

    CAS  PubMed  Google Scholar 

  52. Calogero AE, Gullo G, La Vignera S, Condorelli RA, Vaiarelli A (2015) Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study. Andrology 3:491–495

    Article  CAS  PubMed  Google Scholar 

  53. Condorelli RA, La Vignera S, Bellanca S, Vicari E, Calogero AE (2012) Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology 79:1290–1295

    Article  PubMed  Google Scholar 

  54. Irvine DS (1996) Glutathione as a treatment for male infertility. Rev Reprod 1:6–12

    Article  CAS  PubMed  Google Scholar 

  55. Lenzi A, Picardo M, Gandini L, Lombardo F, Terminali O, Passi F, Dondero F (1994) Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod 9:2044–2050

    Article  CAS  PubMed  Google Scholar 

  56. Walczak-Jedrzejowska R, Wolski JK, Slowikowska-Hilczer J (2013) The role of oxidative stress and antioxidants in male fertility. Cent Eur J Urol 66:60–67

    Article  CAS  Google Scholar 

  57. Ciftci H, Verit A, Savas M, Yeni E, Erel O (2009) Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status. Urology 74:73–76

    Article  PubMed  Google Scholar 

  58. Thérond P, Auger J, Legrand A, Jouannet P (1996) α-Tocopherol in human spermatozoa and seminal plasma: relationships with motility, antioxidant enzymes and leukocytes. Mol Hum Reprod 2:739–744

    Article  PubMed  Google Scholar 

  59. Cho KS, Park CW, Kim CK, Jeon HY, Kim WG, Lee SJ, Kim YM, Lee JY, Choi YD (2013) Effects of Korean ginseng berry extract (GB0710) on penile erection: evidence from in vitro and in vivo studies. Asian J Androl 15:503–507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ (1996) Zinc status and serum testosterone levels of healthy adults. Nutrition 12:344–348

    Article  CAS  PubMed  Google Scholar 

  61. Mouw DR, Latessa RA, Hickner J (2005) Clinical inquiries. What are the causes of hypomagnesemia? J Fam Pract 54:174–176

    PubMed  Google Scholar 

  62. Mirone M, Giannetta E, Isidori AM (2013) Selenium and reproductive function. A systematic review. J Endocrinol Invest 36:28–36

    CAS  PubMed  Google Scholar 

  63. Shindel AW, Xin ZC, Lin G, Fandel TM, Huang YC, Banie L, Breyer BN, Garcia MM, Lin CS, Lue TF (2010) Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. J Sex Med 7:1518–1528

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Stanger O, Fowler B, Piertzik K, Huemer M, Haschke-Becher E, Semmler A, Lorenzl S, Linnebank M (2009) Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother 9:1393–1412

    Article  CAS  PubMed  Google Scholar 

  65. Ng CF, Lee CP, Ho AL, Lee VW (2011) Effect of niacin on erectile function in men suffering erectile dysfunction and dyslipidemia. J Sex Med 8:2883–2893

    Article  CAS  PubMed  Google Scholar 

  66. Tjandra BS, Janknegt RA (1997) Neurogenic impotence and lower urinary tract symptoms due to vitamin B1 deficiency in chronic alcoholism. J Urol 157:954–955

    Article  CAS  PubMed  Google Scholar 

  67. Varjas T, Nowrasteh G, Budán F, Horváth G, Cseh J, Gyöngyi Z, Makai S, Ember I (2011) The effect of fenugreek on the gene expression of arachidonic acid metabolizing enzymes. Phytother Res 25:221–227

    PubMed  Google Scholar 

  68. Stanislavov R, Nikolova V (2003) Treatment of erectile dysfunction with pycnogenol and l-arginine. J Sex Marital Ther 29:207–213

    Article  CAS  PubMed  Google Scholar 

  69. Cormio L, De Siati M, Lorusso F, Selvaggio O, Mirabella L, Sanguedolce F, Carrieri G (2011) Oral l-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology 77:119–122

    Article  PubMed  Google Scholar 

  70. Corazza O, Martinotti G, Santacroce R, Chillemi E, Di Giannantonio M, Schifano F, Cellek S (2014) Sexual enhancement products for sale online: raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo biloba. Biomed Res Int 2014:841798

    Article  PubMed  PubMed Central  Google Scholar 

  71. Schwarz S, Obermuller-Jevic UC, Hellmis E, Koch W, Jacobi G, Biesalski HK (2008) Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr 138:49–53

    CAS  PubMed  Google Scholar 

  72. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, Taylor AM, Waldstreicher J (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride long-term efficacy and safety study group. N Engl J Med 338:557–563

    Article  CAS  PubMed  Google Scholar 

  73. Siddiqui IA, Adhami VM, Saleem M, Mukhtar H (2006) Beneficial effects of tea and its polyphenols against prostate cancer. Mol Nutr Food Res 50:130–143

    Article  CAS  PubMed  Google Scholar 

  74. Vela Navarrete R, Garcia Cardoso JV, Barat A, Manzarbeitia F, Lopez Farre A (2003) BPH and inflammation: pharmacological effects of permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay. Eur Urol 44:549–555

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy

    A. E. Calogero & S. La Vignera

  2. Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy

    A. Aversa

  3. Endocrinology Unit, Medical Department, Maggiore-Bellaria Hospital, Azienda-Usl Bologna, Bologna, Italy

    G. Corona

  4. Deparment of Medicine, University of Padova, Padua, Italy

    A. Ferlin

Authors
  1. A. E. Calogero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Aversa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. La Vignera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Corona
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Ferlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Ferlin.

Ethics declarations

Funding

No specific funding was used in relation to this manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Does not apply to this kind of paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calogero, A.E., Aversa, A., La Vignera, S. et al. The use of nutraceuticals in male sexual and reproductive disturbances: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS). J Endocrinol Invest 40, 1389–1397 (2017). https://doi.org/10.1007/s40618-017-0699-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-017-0699-6

Keywords

Search

Navigation